Keywords
Anxiety
Parkinson’s disease
Electrophysiology
Submitted : 2022-08-31
Accepted : 2022-09-15
Published : 2022-09-30
Abstract
Objective: Clinical and laboratory studies have demonstrated that prelimbic (PrL) and serotonin-4 (5-HT4) receptors may have the key role in regulating anxiety. However, the pathophysiology of anxiety in Parkinson’s disease (PD) remains obscure. In this research, the effects of PrL 5-HT4 receptors on anti-anxiety behaviors in hemiparkinsonian rats were investigated. Methods: PD model rats were used as the research subjects, starting with behavioral changes, from the point of view of electrophysiology, the regulatory effect of PrL 5-HT4 receptors on PD-related anxiety and the possible mechanism were explored. Results: Anxiety-like behaviors were induced via MFB lesion in rats. Intra-PrL injection of 5-HT4 receptors agonist RS67333 induced anti-anxiety effects in both sham and PD group. In the sham group, PrL administration of 5-HT4 receptors antagonist SB204070 produce anti-anxiety effects, but in the PD group, the expression of anxiety-like behavior was increased. Compared to the sham group, the effective dose of the behavioral effects of the two drugs in the PD group was obviously higher. Electrophysiological data suggested that PrL administration of RS67333 (SB204070) increased (decreased) the ?ring activities of ?-aminobutyric acid (GABA) neurons in both groups. Compared with rats in sham group, lesioned rats had a shorter duration of the excitation (inhibition) effects on firing activities of GABA neurons. Conclusion: PrL 5-HT4 receptors regulate anxiety behaviors in PD rats, and its mechanism may be related to the down-regulation of expression or function of PrL 5-HT4 receptors in PD.
References
Mack NR, Deng S, Yang SS, et al., 2022, Prefrontal Cortical Control of Anxiety: Recent Advances. Neuroscientist, 2022: 246361295
Vilaro MT, Cortes R, Mengod G, 2005, Serotonin 5-HT4 Receptors and Their mRNAs in Rat and Guinea Pig Brain: Distribution and Effects of Neurotoxic Lesions. J Comp Neurol, 484(4): 418–439.
Charousaei A, Nasehi M, Babapour V, et al, 2021, The Effect of 5-HT4 Serotonin Receptors in the CA3 Hippocampal Region on D-AP5-Induced Anxiolytic-like Effects: Isobolographic Analyses. Behav Brain Res, 397: 112933.
Jankovic J, Tan EK, 2020, Parkinson's Disease: Etiopathogenesis and Treatment. J Neurol Neurosur PS, 91(8): 795–808.
Pontone GM, Mills KA, 2021, Optimal Treatment of Depression and Anxiety in Parkinson's Disease. Am J Geriatr Psychiatry, 29(6): 530–540.
Hui YP, Wang T, Han LN, et al., 2015, Anxiolytic Effects of Prelimbic 5-HT1A Receptor Activation in The Hemiparkinsonian Rat. Behav Brain Res, 277: 211–220.
Mendez-David I, David DJ, Darcet F, et al., 2014, Rapid Anxiolytic Effects of A 5-HT4 Receptor Agonist are Mediated by a Neurogenesis-Independent Mechanism. Neuropsychopharmacology, 39(6):1366-1378.
Zhang YM, Guo Y, Du CX, et al., 2018, Serotonin? Receptors in the Prelimbic Cortex are Involved in the Regulation of Anxiety-Like Behaviors in the Rat 6-Hydroxydopamine Parkinson’s Disease Model. Chin J Physiol, 61(4): 201–209.
Xu P, Chen A, Li Y, et al., 2019, Medial Prefrontal Cortex in Neurological Diseases. Physiol Genomics, 51(9): 432–442.
Simpson JR, Drevets WC, Snyder AZ, et al., 2001, Emotion-Induced Changes in Human Medial Prefrontal Cortex: II. During Anticipatory Anxiety. Proc Natl Acad Sci USA, 98(2): 688–693.
Kennett GA, Bright F, Blackburn TP, et al., 1997, Anxiolytic-Like Actions of the Selective 5-HT4 Receptor Antagonists SB 204070A and SB 207266A in Rats. Neuropharmacology, 36(4–5): 707–712.
Faye C, Mendez D, Guiard B, et al., 2018, Rapid Anxiolytic Effects of a Serotonin Type 4 Receptor Agonist Involve Prefrontal Cortex/Brainstem Neural Circuit Recruitment. Eur Neuropsychopharm, 28: S21-22.
Amigo J, Diaz A, Pilar-Cuéllar F, et al., 2016, The Absence of 5-HT4 Receptors Modulates Depression and Anxiety-like Responses and Influences the Response of Fluoxetine in Olfactory Bulbectomised Mice: Adaptive Changes in Hippocampal Neuroplasticity Markers and 5-HT1A Autoreceptor. Neuropharmacology, 111: 47–58.
Sun YN, Yao L, Li LB, et al., 2018, Activation and Blockade of Basolateral Amygdala 5-HT6 Receptor Produce Anxiolytic-Like Behaviors in an Experimental Model of Parkinson’s Disease. Neuropharmacology, 137: 275–285.
Di Filippo M, Picconi B, Tozzi A, et al., 2008, The Endocannabinoid System in Parkinson’s Disease. Curr Pharm Des, 14(23): 2337–2346.
Ullmer C, Engels P, Abdel AS, et al., 1996, Distribution of 5-HT4 Receptor mRNA in the Rat Brain. Naunyn Schmiedebergs Arch Pharmacol, 354(2): 210–212.
Suzuki S, Saitoh A, Ohashi M, et al., 2016, The Infralimbic and Prelimbic Medial Prefrontal Cortices Have Differential Functions in the Expression of Anxiety-Like Behaviors in Mice, Behav Brain Res. 304: 120–124.
Negrón-Oyarzo I, Pérez MÁ, Terreros G, et al., 2014, Effects of Chronic Stress in Adolescence on Learned Fear, Anxiety, and Synaptic Transmission in the Rat Prelimbic Cortex. Behav Brain Res, 259: 342–353.
Graeff FG, Viana MB, Mora PO, 1997, Dual Role of 5-HT in Defense and Anxiety. Neurosci Biobehav Rev, 21(6): 791–799.
Kaya AH, Vlamings R, Tan S, et al., 2008, Increased Electrical and Metabolic Activity in the Dorsal Raphe Nucleus of Parkinsonian Rats. Brain Res, 1221: 93–97.